Related Experiment Video
Updated: Aug 14, 2026
14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Decreases in behavioral and striatal neuronal responses to dexamphetamine with aging
1Department of Pharmacology, University of Alberta, Edmonton, Canada.
Pharmacology, Biochemistry, and Behavior
|June 1, 1989
Summary
Older rats show reduced brain responses to dexamphetamine, indicating potential neurotoxicity and impaired dopamine function. This age-related decline affects both neuronal activity and behavioral outcomes.
Area of Science:
- Neuroscience
- Pharmacology
- Aging Research
Background:
- Dexamphetamine (also known as amphetamine) is a stimulant that affects dopaminergic neurotransmission.
- Striatal neurons play a crucial role in motor control and reward pathways, heavily influenced by dopamine.
- Age-related changes in neurotransmitter systems can impact drug responses and neuronal function.
Purpose of the Study:
- To investigate the effects of dexamphetamine on striatal neuronal activity and behavior in mature versus middle-aged rats.
- To determine if dexamphetamine exhibits neurotoxicity in older animals.
- To explore the relationship between age-related dopaminergic impairment and dexamphetamine response.
Main Methods:
- Administration of dexamphetamine (2.5 mg/kg) to mature and middle-aged rats.
- Measurement of striatal multiple unit activity (MUA) using electrophysiology.
- Assessment of behavioral responses to dexamphetamine.
- Retesting middle-aged rats to evaluate response changes over time.
Main Results:
- Mature rats exhibited increased striatal MUA and behavioral activity in response to dexamphetamine.
- Middle-aged rats showed significantly reduced behavioral responses and failed to exhibit neuronal excitation.
- Repeated dexamphetamine administration in older rats did not improve responses and led to decreased spontaneous MUA, suggesting neurotoxicity.
- A potential link between age-related dopaminergic impairment and reduced dexamphetamine efficacy was observed.
Conclusions:
- Age significantly impairs the neuronal and behavioral responses to dexamphetamine in rats.
- Dexamphetamine may exhibit neurotoxic effects in older animals, evidenced by decreased spontaneous MUA.
- Age-related decline in dopaminergic neurotransmission likely contributes to the diminished response to dexamphetamine.
More Related Videos
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
10:19Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Published on: August 22, 2014
Related Concept Videos
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...